BRIEF-Tigenix enrolls first patient in phase Ib/IIa clinical trial of CX611 in severe sepsis
* Enrolls first patient in phase Ib/IIa clinical trial of CX611 in severe sepsis Source text for Eikon: Further company coverage: (Gdynia Newsroom) [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: severe, CX611, trial, clinical, Ib/IIa, phase, patient, first, Newsroom), (Gdynia, coverage, company, Further, Eikon, sepsis Source, Enrolls, sepsis, enrolls, BRIEF-Tigenix
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/uV0wPyjCvOQ/idUSFWN1FK0W6